Stanley Liauw, MD
Associate Professor of Radiation & Cellular Oncology
Dr. Stanley Liauw oversees the genitourinary cancer program and the gastrointestinal cancer program within the Department of Radiation and Cellular Oncology. Since joining the faculty in 2006, Dr. Liauw has implemented several programmatic changes in prostate and gastrointestinal radiation therapy.
Dr. Liauw's primary research interests include clinical outcomes and clinical trials. He oversees the management of several clinical databases which track patient outcomes for more than 2,000 patients. The information collected is used to identify factors that are associated with treatment success and quality of life.
Dr. Liauw is the primary investigator of several clinical trials involving genitourinary and gastrointestinal radiation therapy. These include protocols regarding gene therapy for prostate cancer, bladder preserving treatment for patients with bladder cancer, and stereotactic body radiation therapy for patients with pancreatic cancer.
Dr. Liauw has been the recipient of several research and training awards. He has presented his work at national scientific meetings, and has published manuscripts in a variety of medical journals.
The University of Chicago Medicine
Year Started Practice
University of Texas Southwestern Medical School
Brigham and Women's Hospital, Boston
Shands at the University of Florida, Gainesville, FL
Office Postal Address
Stanley Liauw, MD
Request an appointment online
Learn More About Dr. Liauw
Dr. Liauw was one of seven specialists who cared for a woman battling colorectal cancer during her pregnancy.
View a list of Dr. Liauw's publications through the National Library of Medicine's PubMed online database.